Education
About Us
Working with TipRanks
Follow Us
Niagen Bioscience, Inc. (NAGE)
NASDAQ:NAGE
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 129.42M | $ 99.60M | $ 83.57M | $ 72.05M | $ 67.45M |
| Gross Profit | $ 83.19M | $ 61.59M | $ 50.78M | $ 42.80M | $ 41.49M |
| Operating Income | $ 14.30M | $ 7.73M | $ -5.60M | $ -18.63M | $ -27.07M |
| EBITDA | $ 15.75M | $ 9.21M | $ -3.89M | $ -16.74M | $ -25.45M |
| Net Income | $ 17.38M | $ 8.55M | $ -4.94M | $ -16.54M | $ -27.13M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 64.79M | $ 44.51M | $ 27.17M | $ 20.29M | $ 28.02M |
| Total Assets | $ 106.41M | $ 68.28M | $ 54.96M | $ 54.06M | $ 57.84M |
| Total Debt | $ 2.82M | $ 2.65M | $ 3.28M | $ 4.26M | $ 4.70M |
| Net Debt | $ -61.97M | $ -41.86M | $ -23.90M | $ -16.03M | $ -23.32M |
| Total Liabilities | $ 29.87M | $ 22.18M | $ 26.51M | $ 25.39M | $ 26.11M |
| Stockholders' Equity | $ 76.53M | $ 46.09M | $ 28.46M | $ 28.67M | $ 31.73M |
| Cash Flow | |||||
| Free Cash Flow | $ 13.14M | $ 11.95M | $ 6.97M | $ -15.43M | $ -24.57M |
| Operating Cash Flow | $ 13.44M | $ 12.11M | $ 7.12M | $ -15.10M | $ -24.16M |
| Investing Cash Flow | $ -292.00K | $ -143.00K | $ -143.00K | $ -334.00K | $ -409.00K |
| Financing Cash Flow | $ 6.98M | $ 5.37M | $ -90.00K | $ 7.65M | $ 36.09M |